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College of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USAPigment epithelium-derived factor (PEDF) expression is
downregulated in the kidneys of diabetic rats, and delivery
of PEDF suppressed renal ﬁbrotic factors in these animals.
PEDF has multiple functions including anti-angiogenic,
anti-inﬂammatory and antiﬁbrotic activities. Since the
mechanism underlying its antiﬁbrotic effect remains
unclear, we studied this in several murine models of renal
disease. Renal PEDF levels were signiﬁcantly reduced in
genetic models of type 1 and type 2 diabetes (Akita and
db/db, respectively), negatively correlating with Wnt
signaling activity in the kidneys. In unilateral ureteral
obstruction, an acute renal injury model, there were
signiﬁcant decreases of renal PEDF levels. The kidneys of
PEDF knockout mice with ureteral obstruction displayed
exacerbated expression of ﬁbrotic and inﬂammatory
factors, oxidative stress, tubulointerstitial ﬁbrosis, and
tubule epithelial cell apoptosis, compared to the kidneys of
wild-type mice with obstruction. PEDF knockout enhanced
Wnt signaling activation induced by obstruction, while
PEDF inhibited the Wnt pathway-mediated ﬁbrosis in
primary renal proximal tubule epithelial cells. Additionally,
oxidative stress was aggravated in renal proximal tubule
epithelial cells isolated from knockout mice and suppressed
by PEDF treatment of renal proximal tubule epithelial cells.
PEDF also reduced oxidation-induced apoptosis in renal
proximal tubule epithelial cells. Thus, the renoprotective
effects of PEDF are mediated, at least partially, by inhibition
of the Wnt pathway. Hence, restoration of renal PEDF levels
may have therapeutic potential for renal ﬁbrosis.
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Kidney International (2016) -, -–-R enal ﬁbrosis, mainly categorized as glomerulosclerosisand tubulointerstitial ﬁbrosis, is an advanced pathologicfeature of many acute kidney injuries1 and chronic
kidney diseases.2 This irreversible process causes a progressive
decline of renal functions, eventually leading to renal insuf-
ﬁciency. Currently, there are no effective treatments for the
devastating renal ﬁbrosis.3
Tubules play important roles in maintaining renal func-
tions. In human glomerular nephritis4 and diabetic
nephropathy,5 loss of renal functions correlates more closely
with tubular damage than with glomerular changes. Proximal
tubules are recognized as a signiﬁcant part of tubules carrying
out regulatory functions of water and salt balance, acid-base
homeostasis, and the endocrine system.6 Various kidney dis-
eases are associated with proximal tubule disorders, such as
acute kidney injuries7 and diabetic nephropathy.8–10 More-
over, injuries of proximal tubules alone trigger glomerulo-
sclerosis and tubulointerstitial ﬁbrosis.11 During the renal
ﬁbrotic process, renal proximal tubule epithelial cells (PTECs)
produce extracellular matrix2 and act as immune cells by
expressing and releasing adhesion molecules, cytokines, and
chemokines.12
Pigment epithelium-derived factor (PEDF) is a non-
inhibitory member of the serine protease inhibitor family.13
It has multiple functions14 including antiangiogenesis,15
especially in retinal vascular diseases such as diabetic
retinopathy,16 anti-inﬂammation,17,18 and antiﬁbrosis activ-
ities.19–23 In human kidneys, PEDF protein is highly expressed
in tubules and moderately in glomeruli.24 The PEDF mRNA is
detected in the kidneys of both fetal and adult humans.25
Decreased PEDF expression has been demonstrated in type
1 diabetic rat kidneys with renal ﬁbrosis.19 Delivery of PEDF
into diabetic rats suppresses the renal levels of ﬁbrotic
markers,23 suggesting an antiﬁbrotic activity of PEDF. How-
ever, PEDF’s function in the tubules and the mechanism
underlying PEDF’s antiﬁbrosis activity remain elusive.
Aberrant activation of the canonical Wnt pathway is
reported in kidney diseases including obstructive nephropa-
thy,26,27 Adriamycin-induced nephropathy,28 and type 1 and 2
diabetic nephropathy.29 In an obstructive nephropathy model1
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Figure 1 | Downregulated pigment epithelium-derived factor (PEDF) and activated Wnt signaling in the kidneys of Akita mice. (a)
Western blot analysis and (b–h) densitometry quantiﬁcation of PEDF, phosphorylated low-density lipoprotein receptor–related protein 6
(p-LRP6), total LRP6, nonphosphorylated b-catenin (non–p-b-catenin), total b-catenin, connective tissue growth factor (CTGF), and collagen
type III in kidney homogenates from 3-month-old Akita mice and wild-type (WT) controls (N ¼10). Each lane represents an individual mouse.
&P < 0.05, &&P < 0.01, Akita versus WT mice. All values are expressed as mean  SD.
bas i c re sea r ch X He et al.: PEDF and renal tubulointerstitial ﬁbrosisi.e., unilateral ureteral obstruction (UUO), 16 Wnt ligands,
and 6 Frizzled receptors are upregulated.26 The Wnt pathway
promotes myoﬁbroblast differentiation.30 Persistent activa-
tion of this pathway further drives the transition from acute
kidney injury to chronic kidney disease.31 A number of Wnt
target genes are also reported to contribute to renal ﬁbrosis,
including ﬁbrotic factors such as ﬁbronectin and ﬁbroblast-
speciﬁc protein 1.32 Plasminogen activator inhibitor-1,
another target gene of Wnt signaling, stimulates the accumu-
lation of immune cells and myoﬁbroblasts in the kidney.33,34
On the other hand, inhibitors of the Wnt pathway, such
as ICG-001,31 secreted frizzled-related protein 4,27 and
dickkopf-1,26 attenuate renal ﬁbrosis. Interestingly, levels of
b-catenin are predominantly induced in the tubules of the
kidneys with UUO,26 diabetic nephropathy,29 Adriamycin-
induced nephropathy,35 and ischemia/reperfusion renal injury.31
Our previous study identiﬁed PEDF as an endogenous
inhibitor of the Wnt signaling pathway36; it is possible that
the antiﬁbrotic effect of PEDF is mediated via inhibition2of the Wnt signaling pathway. The present study has
addressed the following questions: (i) What is the role of
PEDF in tubulointerstitial ﬁbrosis? (ii) Does PEDF knockout
(KO) affect renal tubule epithelial cells, a group of cell types
crucial for the regulation of renal inﬂammatory processes
and tubulointerstitial ﬁbrosis? (iii) What is the underlying
molecular mechanism mediating the antiﬁbrotic effect of
PEDF?
RESULTS
Inverse correlations between PEDF levels and Wnt signaling
activation in diabetic kidneys
The renal PEDF levels have not been previously examined in
genetic models of types 1 and 2 diabetes mellitus. Thus, we
examined PEDF protein levels in the kidneys of 3-month-old
Akita mice, a type 1 diabetic model, and 6-month-old db/db
mice, a type 2 diabetic model. Renal PEDF was signiﬁcantly
downregulated in these 2 diabetic models (Figures 1a and b
and 2a and b), accompanied by increased levels of the ﬁbrosisKidney International (2016) -, -–-
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Figure 2 | Downregulated pigment epithelium-derived factor (PEDF) and activated Wnt signaling in the kidneys of db/db mice. (a)
Western blot analysis and (b–h) densitometry quantiﬁcation of PEDF, phosphorylated low-density lipoprotein receptor-related protein 6
(p-LRP6), total LRP6, nonphosphorylated b-catenin (non–p-b-catenin), total b-catenin, connective tissue growth factor (CTGF), and collagen
type III in kidney homogenates from 6-month-old db/db mice and wild-type (WT) controls (N ¼ 10). Each lane represents an individual mouse.
&&P < 0.01, db/db versus WT. All values are expressed as mean  SD.
X He et al.: PEDF and renal tubulointerstitial ﬁbrosis ba s i c re sea r chfactors, connective tissue growth factor (CTGF) and collagen
type III (Figures 1 and 2). To establish an inverse correlation
between PEDF levels and Wnt signaling activation, we further
evaluated phosphorylated low-density lipoprotein receptor–
related protein 6 (p-LRP6) and total LRP6, a coreceptor of the
Wnt pathway, and nonphosphorylated b-catenin (non–p-b-
catenin) and total b-catenin, an effector of the canonical Wnt
signaling pathway. As shown in Figures 1 and 2, renal p-LRP6
and non–p-b-catenin levels were signiﬁcantly elevated in
these 2 diabetic mouse models compared with those in their
respective age- and genetic background–matched nondiabetic
controls, suggesting activated Wnt signaling in these diabetic
kidneys. Taken together, these results demonstrated an inverse
correlation between renal PEDF levels and Wnt signaling
activation in these genetic diabetic models.
PEDF levels were decreased in kidneys with tubulointerstitial
ﬁbrosis
To understand the role of PEDF in nondiabetic kidneys with
ﬁbrosis, we used an UUO model that is characterized
by tubulointerstitial ﬁbrosis and tubular injury.37 As PEDFKidney International (2016) -, -–-expression has not been previously examined in the kidneys
with UUO, we plotted the time course of renal PEDF changes.
At days 3 and 5 post-surgery, renal PEDF levels were both
signiﬁcantly downregulated in UUO kidneys compared with
those in the sham control (Figure 3a and b). Decreased PEDF
levels were accompanied by increases in a-smooth muscle
actin and collagen type III (Figure 3a and b), suggesting a
negative correlation between PEDF levels and ﬁbrosis in UUO
kidneys. We further localized and compared PEDF expression
in sham kidneys and UUO kidneys by immunohistochem-
istry. PEDF was abundantly expressed in the tubules of sham
controls (Figure 3c). As shown by in situ hybridization, the
PEDF mRNA was also predominantly detected in tubules
(Supplementary Figure S2A). After 5 days of UUO, PEDF was
downregulated in renal tubules at the protein level (Figure 3c
and d) and at the mRNA level (Supplementary Figure S1).
KO of PEDF exacerbated tubulointerstitial ﬁbrosis
To further delineate the effect of PEDF on renal tubu-
lointerstitial ﬁbrosis, we used PEDF KO (PEDF–/–) mice.
PEDF KO was veriﬁed in the kidney using Western blot3
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Figure 3 | Downregulation of pigment epithelium-derived factor (PEDF) in the kidney with tubulointerstitial ﬁbrosis. (a) Western blot
analysis and (b) densitometry quantiﬁcation of PEDF, a-smooth muscle actin (a-SMA), and collagen type III in kidney homogenates of the sham
group and unilateral ureteral obstruction (UUO) groups at days 3 and 5 postsurgery. Each lane represents an individual mouse. (c) Repre-
sentative images of immunohistochemical staining of PEDF and (d) quantiﬁcation of PEDF signal in kidney sections at day 5 postsurgery. Bar ¼
100 mm. N ¼ 5–6 per group. &P < 0.05; &&P < 0.01. All values are expressed as mean  SD. GAPDH, glyceraldehyde-3-phosphate dehydro-
genase; IHC, immunohistochemistry.
bas i c re sea r ch X He et al.: PEDF and renal tubulointerstitial ﬁbrosisanalysis of PEDF (Supplementary Figure 2A) and immuno-
histochemistry (Figure 3c). Moreover, the PEDF mRNA was
not detected in PEDF–/– kidneys by in situ hybridization
(Supplementary Figure 2B). Under normal conditions,
2-month-old PEDF–/– mice did not exhibit abnormal renal
functions, as their 24-hour urinary albumin excretion, uri-
nary albumin/creatinine ratio, and glomerular ﬁltration rate
were not signiﬁcantly different from those of age-matched
wild-type (WT) mice (Supplementary Figure S3A–C). Peri-
odic acid–Schiff staining also showed normal glomerular and4tubular structures in PEDF–/– kidneys (Supplementary
Figure S3D).
At day 5 post-UUO surgery, mRNA levels of collagen types
I and III, transforming growth factor-b1 (TGF-b1), and
ﬁbronectin were signiﬁcantly higher in PEDF–/–/UUO kid-
neys than those in WT/UUO kidneys (Figure 4a–d). In
agreement with the increased mRNA levels, signiﬁcantly
elevated protein levels of collagen types I and III and TGF-b1
were detected in PEDF–/–/UUO kidneys compared with
WT/UUO kidneys (Figure 4e–h). Interestingly, levels ofKidney International (2016) -, -–-
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Figure 4 | Exacerbated tubulointerstitial ﬁbrosis in pigment epithelium-derived factor knockout (PEDF–/–) mice after unilateral ureteral
obstruction (UUO). (a–d) Real-time polymerase chain reaction (PCR) measurement of mRNA levels of collagen types I and III, transforming
growth factor-b1 (TGF-b1), and ﬁbronectin in kidneys from wild-type (WT) and PEDFL/L mice at day 5 post-surgery (N ¼ 5–6). (e) Western blot
analysis and (f–h) densitometry quantiﬁcation of collagen types I and III and TGF-b1 in kidney homogenates at day 5 postsurgery (N ¼ 5–6).
Each lane represents an individual mouse. (i) Enzyme-linked immunosorbent assay (ELISA) measurement of ﬁbronectin in kidney homogenates
at day 5 postsurgery (N ¼ 8–12). (j) Representative images of picro-sirius red staining of kidney sections at day 5 postsurgery under a light
microscope (upper panels) and under a polarized microscope (lower panels). Bar ¼ 200 mm. (k) Quantiﬁcation of collagen deposition using
a polarized microscope (N ¼ 5–6). *P < 0.05, **P < 0.01, WT/UUO versus WT/sham; YP < 0.05, YYP < 0.01, PEDFL/L/UUO versus WT/UUO.
All values are expressed as mean  SD.
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X He et al.: PEDF and renal tubulointerstitial ﬁbrosis ba s i c re sea r chTGF-b receptor types I and II were also signiﬁcantly higher in
PEDF–/–/UUO kidneys (Supplementary Figure S4). In agree-
ment with renal ﬁbronectin mRNA levels, kidney-derived
ﬁbronectin protein levels were signiﬁcantly higher in
PEDF–/–/UUO kidneys (2.68  0.49 ng/mg of total proteins)
compared with WT/UUO kidneys (2.18  0.23 ng/mg)
(Figure 4i). In the sham groups, however, KO of PEDF did
not alter either the mRNA or protein levels of those ﬁbrotic
factors (Figure 4a–i). Collagen deposition was evaluated by
picro-sirius red staining. Semiquantiﬁcation of images taken
under a polarized microscope showed that UUO for 5 days
induced a dramatic increase in collagen deposition in the
kidneys of PEDF–/– mice compared with WT kidneys
(Figure 4j and k).
PEDF KO enhanced oxidative stress and inﬂammation in UUO
kidneys
UUO is known to induce oxidative stress and inﬂammation,
which promote the progression of tubulointerstitial ﬁbrosis.38
3-Nitrotyrosine (3-NT) is a product of tyrosine nitration
and a marker of oxidative stress. At day 5 post-surgery, both
WT/UUO and PEDF–/–/UUO mice showed signiﬁcantly
elevated 3-NT levels in the kidneys (0.591  0.155 ng/mg and
0.728  0.226 ng/mg, respectively) compared with the sham
controls. At day 10 post-surgery, the PEDF–/–/UUO group
displayed signiﬁcantly higher 3-NT levels (0. 896  0.18 ng/
mg) compared with the WT/UUO group (0. 679  0.124 ng/
mg) (Figure 5a).
To evaluate the impact of PEDF ablation on kidney
inﬂammation, we measured renal levels of inﬂammatory
factors including intercellular adhesion molecule-1 (ICAM-1)
and tumor necrosis factor-a. At day 5 post-surgery,
expression of ICAM-1 and tumor necrosis factor-a was
signiﬁcantly elevated at the mRNA levels (Figure 5b and c)
and protein levels (Figure 5d and e) in PEDF–/–/UUO kidneys
relative to WT/UUO controls. As shown by enzyme-linked
immunosorbent assay (ELISA), UUO for 5 and 10 days
induced signiﬁcantly higher ICAM-1 levels in PEDF–/–/UUO
kidneys (0.475  0.083 ng/mg and 0.381  0.034 ng/mg,
respectively) relative to WT/UUO kidneys (0.404  0.05
ng/mg and 0.344  0.015 ng/mg, respectively) (Figure 5g). In
addition, signiﬁcantly higher mRNA levels of interleukin-6
and macrophage colony–stimulating factor were also detec-
ted in PEDF–/–/UUO kidneys compared with WT/UUO
controls (Supplementary Figure S5A and B). During kidney
injuries, inﬂammatory monocytes inﬁltrate the injury sites=
Figure 5 | Worsened oxidative stress and inﬂammation in the kidney
after unilateral ureteral obstruction (UUO). (a) Enzyme-linked immun
homogenates from wild-type (WT) and PEDF–/– mice at days 5 and 10 p
measurement of mRNA levels, (d) Western blot analysis, and (e,f) densit
tumor necrosis factor-a (TNF-a), and cluster of differentiation 68 (CD68)
represents an individual mouse. (g) ELISA measurement of ICAM-1 in ki
sentative images of immunostaining of CD68 and (i) quantiﬁcation of CD
WT/UUO versus WT/sham; YP < 0.05, YYP < 0.01, PEDF–/–/UUO versus WT/
3-phosphate dehydrogenase.
Kidney International (2016) -, -–-and differentiate into macrophages.39 We detected mono-
cytes/macrophages by a speciﬁc marker cluster of differenti-
ation 68 (CD68).40 As shown in Figure 5d, f, h, and i,
PEDF–/–/UUO kidneys at day 5 showed more prominent in-
creases of monocyte/macrophage inﬁltration in the tubu-
lointerstitial areas relative to those of WT/UUO controls.
Signiﬁcant increase of renal tubule epithelial cell apoptosis in
PEDF–/–/UUO kidneys
Increases in inﬂammation and oxidative stress in UUO
models are known to result in progressive renal tubule
epithelial cell death.38 At day 5 post-surgery, PEDF KO led to
a signiﬁcant decrease in the epithelial cell marker E-cadherin,
but myoﬁbroblast marker a-smooth muscle actin was un-
changed in UUO kidneys (Figure 6a–c), suggesting an
increased loss of tubule epithelial cells and unaffected myo-
ﬁbroblast population in PEDF–/–/UUO kidneys relative to the
WT/UUO group. Loss of tubule epithelial cells is primarily via
the apoptosis pathway.37 Prevalent apoptosis was detected in
UUO groups at day 10 post-surgery, whereas PEDF–/–/UUO
group displaying signiﬁcantly more terminal deoxy-
nucleotidyltransferase–mediated dUTP nick end-labeling
(TUNEL)–positive cells over the WT/UUO group
(Figure 6d and e). There was no signiﬁcant difference in the
numbers of apoptotic cell between PEDF–/–/sham kidneys and
WT/sham kidneys. Because apoptosis of tubule epithelial cells
was caspase-3 dependent in the UUO model,41 we measured
caspase-3 activation. At day 5 post-surgery, a signiﬁcant in-
crease in cleaved caspase-3 was detected in PEDF–/–/UUO
kidneys compared with WT/UUO controls (Figure 6f and g).
PEDF KO enhanced UUO-induced Wnt signaling activation
Our previous study established PEDF as an endogenous in-
hibitor of the Wnt pathway.36 Thus, we further evaluated the
impacts of PEDF KO on Wnt signaling activation in the UUO
model. At day 5 post-UUO, renal levels of p-LRP6, total
LRP6, non–p-b-catenin, and total b-catenin were signiﬁcantly
higher in the PEDF–/–/UUO group compared with the WT/
UUO group (Figure 7a–e). PEDF KO did not affect LRP6
mRNA levels in both UUO groups and sham groups
(Figure 7f), consistent with our previous report showing that
PEDF regulated the LRP6 protein but not the LRP6 mRNA
level.36 Moreover, PEDF KO did not affect p-LRP6 and
non–p-b-catenin levels in the sham groups (Figure 7b and d)
or the levels of the canonical Wnt ligands (Wnt1, Wnt2,
Wnt2b, Wnt3, Wnt3a, Wnt8a, Wnt9a, Wnt10b, and Wnt16)s of pigment epithelium-derived factor knock-out (PEDF–/–) mice
osorbent assay (ELISA) measurement of 3-nitrotyrosine in kidney
ostsurgery (P ¼ 8–12). (b,c) Real-time polymerase chain reaction
ometry quantiﬁcation of intercellular adhesion molecule 1 (ICAM-1),
in kidney homogenates at day 5 postsurgery (N ¼ 5–6). Each lane
dney homogenates from 5- and 10-day UUO (N ¼ 8–12). (h) Repre-
68–positive cells in kidney sections at day 5 postsurgery **P < 0.01,
UUO. All values are expressed as mean  SD. GAPDH, glyceraldehyde-
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Figure 6 | Signiﬁcant increase of renal tubule epithelial cell apoptosis in pigment epithelium-derived factor knock-out (PEDF–/–)
kidneys after unilateral ureteral obstruction (UUO). (a) Western blot analysis and (b,c) densitometry quantiﬁcation of E-cadherin and a-
smooth muscle actin (a-SMA) in kidney homogenates from wild-type (WT) and PEDF–/– mice at day 5 postsurgery (N ¼ 5–6). (d) Representative
images of terminal deoxynucleotidyltransferase–mediated dUTP nick end-labeling (TUNEL) (red) and E-cadherin (green) staining of kidney
sections from mice as indicated at day 10 postsurgery. Bar ¼ 50 mm. (e) TUNEL-positive cells were counted and averaged in 8 ﬁelds per
specimen (N ¼ 5–8). (f) Western blot analysis and (g) densitometry quantiﬁcation of cleaved caspase-3 in kidney homogenates from WT
and PEDF–/– mice at day 5 postsurgery (N ¼ 5–6). Each lane represents an individual mouse. **P < 0.01, WT/UUO versus WT/sham; YP < 0.05,
YYP < 0.01, PEDF–/–/UUO versus WT/UUO. All values are expressed as mean  SD.
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Figure 7 | Enhanced Wnt signaling activation in the kidneys of pigment epithelium-derived factor knock-out (PEDFL/L) kidneys after
unilateral ureteral obstruction (UUO). (a)Western blot analysis and (b–e) densitometry quantiﬁcation of phosphorylated low-density lipoprotein
receptor–related protein 6 (p-LRP6), total LRP6, nonphosphorylated b-catenin (non–p-b-catenin), and total b-catenin in kidney homogenates from
wild-type (WT) and PEDF–/– mice at day 5 postsurgery (N¼ 5–6). Each lane represents an individual mouse. (f) Real-time polymerase chain reaction
measurement of mRNA levels of LRP6 in 5-day sham and UUO kidneys (N ¼ 5–6). (g) Representative images of X-gal staining reﬂecting Wnt
signaling activation (blue) in kidney sections from theWT/Axin2þ/LacZ and PEDF–/–/Axin2þ/LacZ mice at day 5 postsurgery. Bar¼ 500 mm. *P< 0.05,
**P < 0.01, WT/UUO versus WT/sham; YP < 0.05, PEDF–/–/UUO versus WT/UUO. All values are expressed as mean  SD.
X He et al.: PEDF and renal tubulointerstitial ﬁbrosis ba s i c re sea r chin both sham and UUO groups (Supplementary Figure S6).
To further conﬁrm Wnt signaling activation in vivo, we
used a transgenic Wnt signaling reporter mouse line, axis
inhibition protein 2/LacZ (Axin2þ/LacZ) mice, in which theKidney International (2016) -, -–-b-galactosidase reporter gene is expressed in response to Wnt
signaling activation.42 At day 5 post-surgery, X-gal staining
showed that b-galactosidase was signiﬁcantly induced in
PEDF–/–/Axin2þ/LacZ kidneys with UUO compared with that9
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signaling activation was detected predominantly in tubules,
which was consistent with previous reports on the same
model.26,27 There was no signiﬁcant difference in Wnt
signaling activation in mice with sham surgery. Taken
together, these results indicated that PEDF KO exacerbated
Wnt signaling activation in UUO kidneys.
PEDF inhibited Wnt pathway–mediated ﬁbrosis in renal
PTECs
Next, we evaluated the effect of PEDF on Wnt-mediated
ﬁbrosis in mouse primary renal PTECs. PTECs were
intensely immunostained by an antibody for the proximal
tubule marker sodium-dependent glucose cotransporter 1
and very weakly by the antibody for the distal convoluted
tubule marker sodium-chloride symporter (Supplementary
Figure S7). In PEDF–/– PTECs, Wnt3a-conditioned medium
(WCM) induced more prominent increases in p-LRP6 and
non–p-b-catenin compared with those in WT PTECs
(Figure 8a and b), consistent with the in vivo observations of
Wnt signaling in PEDF–/–/UUO kidneys. Moreover, WCM
induced more prominent increases of Wnt-targeted genes
ﬁbronectin43 and CTGF44 in PEDF–/– PTECs (Figure 8a
and b). Interestingly, TGF-b1, a master regulator of tubu-
lointerstitial ﬁbrosis, was also upregulated by WCM, which
was further enhanced by PEDF KO (Figure 8a and b). PEDF
treatment signiﬁcantly reduced levels of p-LRP6, non–p-b-
catenin, ﬁbronectin, CTGF, and TGF-b1 in WT PTECs
(Figure 8c and d). In addition, a luciferase-based promoter
activity assay showed that PEDF treatment suppressed WCM-
induced b-catenin transcriptional activity in a human renal
PTEC line (Figure 8e).
Protective effect of PEDF on renal PTECs
Increased oxidative stress in the UUO model was reported
to cause renal tubule cell impairment.38 Therefore, we exam-
ined the effect of PEDF on oxidative stress. WT PTECs and
PEDF–/– PTECs were exposed to 4-hydroxynonenal to mimic
oxidative stress in the UUOmodel. 4-Hydroxynonenal induced
a 4-fold increase in reactive oxygen species (ROS) generation
in PEDF–/– PTECs compared with the 3-fold ROS increase
in WT PTECs (Figure 9a). Administration of PEDF signiﬁ-
cantly suppressed 4-hydroxynonenal–induced ROS generation
in WT PTECs (Figure 9b) and HKC-8 cells (Figure 9c).
Oxidative stress–induced tubule epithelial cell death was
further evaluated byTUNEL staining and trypan blue exclusion=
Figure 8 | Inhibition of the Wnt-mediated ﬁbrosis by pigment epith
densitometry quantiﬁcation of phosphorylated low-density lipoprotein r
b-catenin (non–p-b-catenin), total b-catenin, connective tissue growth fac
(a,b) in primary proximal tubule epithelial cells (PTECs) from wild-type (
treated with Wnt3a-conditioned medium (WCM) and indicated concentr
(L or LCM) as a control. (e) Luciferase activity in HKC-8/Topﬂash cells and
of human PEDF for 24 hours (N ¼ 3). *P < 0.05, **P < 0.01, WT PTECsþW
PTECsþWCM; $P < 0.05, $$P < 0.01, WT PTECsþWCMþPEDF versus WT
eraldehyde-3-phosphate dehydrogenase.
Kidney International (2016) -, -–-assay. As shown in Figure 9d–f, PEDF protein and adenovirus-
mediated expression of PEDF signiﬁcantly protected HKC-8
cells from 4-hydroxynonenal–induced cell death.
DISCUSSION
This study demonstrated that PEDF was signiﬁcantly down-
regulated in the kidneys of the UUO and type 1 and 2 diabetic
models. Using PEDF–/– mice and PTECs from PEDF–/– mice,
this study further demonstrated that PEDF possesses anti-
ﬁbrotic and antioxidant activities in the kidney. Furthermore,
using Wnt signaling reporter mice, this study showed that
PEDF KO aggravated Wnt signaling activation induced by
UUO. Also, our results showed an inverse correlation between
Wnt signaling activation and PEDF levels in the kidneys of
UUO and type 1 and 2 diabetic models. PEDF protein sup-
pressed Wnt ligand–induced expression of ﬁbrotic factors in
renal tubule epithelial cells. These observations suggest that
PEDF’s inhibition of Wnt signaling represents a mechanism
responsible for its antiﬁbrotic effect.
In renal disease models characterized by tubulointerstitial
ﬁbrosis, such as UUO,26,27 Adriamycin-induced nephropa-
thy,35 and ischemia/reperfusion renal injury,31 increased
b-catenin was predominantly detected in renal tubules, sug-
gesting that tubule epithelial cells are the major sites for Wnt
signaling activation. To verify Wnt signaling activation in vivo,
this study used Wnt signaling reporter mice, showing that
UUO induced higher Wnt signaling activity in PEDF–/– kid-
neys, primarily in the tubules, compared with that in WT
kidneys. Our previous study demonstrated that PEDF bound
to the Wnt signaling coreceptor LRP6 and downregulated
p-LRP6 and total LRP6 protein levels.36 Consistently, higher
p-LRP6 and total LRP6 protein levels were detected in
PEDF–/–/UUO kidneys compared with WT/UUO kidneys.
However, PEDF KO did not affect LRP6 mRNA levels in
either the sham or UUO group, further conﬁrming that PEDF
regulates LRP6 at the protein levels. In agreement, knocking
out another Wnt inhibitor, a very low-density lipoprotein
receptor, resulted in increased LRP6 protein levels but un-
changed LRP6 mRNA levels.45 Taken together, these results
indicate that PEDF is indeed an endogenous inhibitor of Wnt
signaling in the kidney.
Previously, we reported that Wnt signaling promoted
inﬂammation and oxidative stress.46 In this study, PEDF–/–/
UUO mice displayed enhanced Wnt signaling activation,
correlating with exacerbated monocytes/macrophages inﬁl-
tration and higher levels of ICAM-1, tumor necrosis factor-a,elium-derived factor (PEDF). (a,c) Western blot analysis and (b,d)
eceptor–related protein 6 (p-LRP6), total LRP6, nonphosphorylated
tor (CTGF), ﬁbronectin and transforming growth factor beta 1 (TGF-b1)
WT) mice and PEDF knockout (PEDF–/–) mice and (c,d) in WT PTECs
ations of human PEDF for 24 hours, with L cell conditioned medium
HKC-8/Fopﬂash cells treated with WCM and indicated concentrations
CM versus WT PTECsþLCM; YP < 0.05, PEDF–/– PTECsþWCM versus WT
PTECsþWCM. All values are expressed as mean  SD. GAPDH, glyc-
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Figure 9 | Protective effect of pigment epithelium-derived factor (PEDF) on renal tubule epithelial cells under oxidative stress. (a–c)
Measurement of reactive oxygen species (ROS) generation (a) in primary renal proximal tubule epithelial cells (PTECs) from wild-type (WT) and
pigment epithelium-derived factor knock-out (PEDF–/–) mice treated with 30 mM 4-hydroxynonenal (4-HNE) for 3 hours, (b) in WT PTECs treated
with 30 mM 4-HNE and indicated concentrations of human PEDF for 3 hours, and (c) in HKC-8 cells treated with 10 mM 4-HNE and indicated
concentrations of PEDF for 1 hour. (d) Terminal deoxynucleotidyltransferase–mediated dUTP nick end-labeling (TUNEL) staining of apoptosis in
HKC-8 cells (red), with the nuclei counterstained by 40,6-diamidino-2-phenylindole (blue). Bar ¼ 200 mm. (e,f) Cell viability measured by trypan
blue exclusion assay (e) in HKC-8 cells treated with 10 mM 4-HNE and indicated concentrations of human PEDF for 24 hours and (Continued)
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PEDF protein potently suppressed ROS generation and
attenuated the expression of Wnt-target genes ﬁbronectin29
and CTGF.47 These observations suggest that the antiﬁbrotic
and antioxidant effects of PEDF are mediated, at least in part,
through inhibition of Wnt signaling.
Our results further demonstrated that PEDF KO exacer-
bated tubule epithelial cell apoptosis in UUO kidneys, whereas
PEDF protein attenuated renal PTEC apoptosis, suggesting
a novel protective effect of PEDF on tubule epithelial
cells. However, Wnt signaling was reported to promote tu-
bule epithelial cell survival48; thus, the antiapoptotic effect of
PEDF cannot be directly attributed to the inhibition of
Wnt signaling. It is possible that PEDF inhibits Wnt
signaling, resulting in attenuated Wnt-regulated inﬂamma-
tion and oxidative stress, which subsequently ameliorates
tubule epithelial cell apoptosis. Moreover, enhanced Wnt
signaling activation is also supported by overexpression of the
Wnt target genes Snail-1 and Twist,49 suppressors of epithe-
lial cell marker E-cadherin,50,51 which might also explain the
further decrease in E-cadherin in PEDF–/–/UUO kidneys.
Interestingly, we did not detect higher levels of myoﬁbroblast
marker a-smooth muscle actin in PEDF–/–/UUO kidneys,
suggesting that PEDF KO does not affect the myoﬁbroblast
population in the UUO model.
Others52,53 and our group19,23 have independently re-
ported that PEDF downregulated TGF-b1 levels in diabetic
kidneys, human renal PTECs, and human glomerular
mesangial cells. In this study, we found increased TGF-b1
expression in PEDF–/–/UUO kidneys and PEDF–/– PTECs,
further conﬁrming an inhibitory effect of PEDF on TGF-b1
expression. We also observed that Wnt3a alone was sufﬁcient
to upregulate TGF-b1, accompanied by Wnt signaling acti-
vation in PTECs, and PEDF counteracted Wnt3a’s induction
of TGF-b1. It is possible that PEDF suppresses TGF-b1
expression through inhibiting the Wnt pathway. However,
this study does not exclude the possibility that PEDF might
regulate the cross-talk between the Wnt and TGF-b pathways
to affect TGF-b1 expression. This study also showed increases
in TGF-b receptor types I and II in PEDF–/–/UUO kidneys. It
remains to be elucidated how TGF-b1 and its receptors are
upregulated in PEDF–/– kidneys.
Being a multifunctional protein that interacts with multi-
ple cell surface proteins,14 PEDF was also reported to regulate
other ﬁbrotic signaling pathways. A PEDF-derived peptide
downregulated the expression of platelet-derived growth
factor receptor in ﬁbrotic livers and hepatic stellate cells.54 We
also observed that PEDF suppressed TGF-b1–induced ﬁbro-
nectin and CTGF expression in human mesangial cells23 and
human renal tubule epithelial cells (Supplementary
Figure S8). It remains to be studied whether PEDF regulates=
Figure 9 | (Continued) (f) in HKC-8 cells treated with 10 mm 4-HNE and ad
or adenovirus-mediated expression of PEDF (Ad-PEDF) for 24 hours. *
PTECsþ4-HNE versus WT PTECsþ4-HNE. &&P < 0.01, 4-HNE versus cont
expressed as mean  SD.
Kidney International (2016) -, -–-the platelet-derived growth factor and TGF-b signaling
pathways in renal ﬁbrosis models.
This study demonstrated that in adult mouse kidneys, the
PEDF protein and mRNA were abundantly expressed in tu-
bules and moderately in glomeruli, consistent with previous
observations of renal distribution of PEDF.24,25 After UUO,
both the PEDF mRNA and protein levels were signiﬁcantly
decreased. The decreased mRNA and protein levels of PEDF
in UUO kidneys might be a result of tubule epithelial cell loss,
as these cells express abundant amount of PEDF. However, it
is not known whether epithelial cell loss is a plausible
explanation of decreased PEDF levels in diabetic kidneys.
PEDF is a substrate of matrix metalloproteinase 2 and 9.22,55
As matrix metalloproteinases 2 and 9 are activated in
UUO56,57 and diabetes,58 it is possible that matrix metal-
loproteinase 2 and 9 activation is a potential mechanism for
decreased PEDF levels in these models.
In summary, this study showed that decreased renal PEDF
levels in UUO and diabetic models may account for the
progression of renal tubulointerstitial ﬁbrosis through the
mediation of Wnt signaling. These ﬁndings provide a new
pathogenic mechanism for tubulointerstitial ﬁbrosis and
suggest the therapeutic potential of PEDF for renal ﬁbrosis.
METHODS
Animal models and measurements of renal functions
PEDF–/– mice in C57BL/6J background was kindly provided by
Regeneron Pharmaceuticals (Tarrytown, NY). PEDF–/– mice were
crossbred with a Wnt reporter strain Axin2þ/LacZ in B6.129
background42; F2 homozygous PEDF–/–/Axin2þ/LacZ and littermates
WT/Axin2þ/LacZ mice were used for this study. Eight-week-old mice
were randomly assigned to sham surgery or the UUO group. Brieﬂy,
UUO was achieved in anesthetized mice by double ligations at the
left ureter using 4-0 silk. The ureters of sham mice were exposed and
manipulated without ligations.26 Left kidneys were collected for
analyses at day 5 or 10 post-surgery. Twenty-four–hour urine was
collected, and creatinine was measured by high-performance liquid
chromatography, as previously described.29 Urinary albumin was
measured using a murine microalbuminuria ELISA kit (Exocell,
Philadelphia, PA). The glomerular ﬁltration rate was measured as
previously described.59
Cell culture, luciferase, ROS, and trypan blue exclusion assay
Human renal PTEC line HKC-8 cells (provided by Dr. L. Racusen,
Johns Hopkins University, Baltimore, MD) were maintained as
previously described.60 Pretreatment of PEDF proteins was always
performed in cell assays, using bovine serum albumin as the control
protein. Adenovirus-mediated expression of green ﬂuorescence
protein or adenovirus-mediated expression of PEDF (1.25  107
pfu/ml) was used as previously described.60 Topﬂash activity was
performed as previously described.61 ROS generation was measured
by CM-H2DCFDA (Thermo Fisher Scientiﬁc, Grand Island,
NY) according to the manufacturer’s instructions. Cell viabilityenovirus-mediated expression of green ﬂuorescence protein (Ad-GFP)
*P < 0.01, WT PTECsþ4-HNE versus WT PTECs; YYP < 0.01, PEDF–/–
rol; $P < 0.05, $$P < 0.01, 4-HNEþPEDF versus 4-HNE. All values are
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Scientiﬁc). Brieﬂy, cell pellets were collected and washed with
phosphate-buffered saline 3 times and then resuspended in
phosphate-buffered saline at a concentration of 105 to 106/ml. After
incubation with trypan blue dye (0.4%) at a 1:1 ratio (vol/vol) for
5 minutes, viable and dead cells were counted using the Cellometer
(Nexcelom, Lawrence, MA).
Primary culture of renal tubule epithelial cells
Isolation of mouse PTECs was performed as previously described.62
Brieﬂy, the renal cortex was dissected, minced, and digested at 37C
with agitation for 30 minutes. The solution was then ﬁltered
sequentially through size 80 and size 200 sieves (Sigma-Aldrich, St.
Louis, MO). The cells between size 80 to 200 were collected and
maintained in renal epithelial culture medium (ATCC, Manassas,
VA). Cells of passages 2 to 5 were used for experiments.
Real-time reverse transcriptase polymerase chain reaction
Real-time reverse transcriptase polymerase chain reaction was per-
formed as described previously.29 Sequences of primers for genes
were obtained from the qPrimerDepot website (Supplementary
Table S1).
Western blot analysis and ELISA
Western blot analysis was performed as previously described.36 An-
tibodies used are listed in Supplementary Table S2. Individual bands
were semiquantiﬁed by densitometry using the AlphaView software
(AlphaView, Santa Clara, CA). Levels of ﬁbronectin were determined
by a mouse ﬁbronectin ELISA kit (Assaypro, Charles, MO), 3-NT by
a mouse 3-NT ELISA kit (EMD Millipore, Temecula, CA), and
ICAM-1 by a mouse ICAM-1 ELISA kit (R&D Systems, Minneapolis,
MN). ELISA results were normalized to total amount of proteins.
Immunohistochemistry, picro-sirius red staining, TUNEL, and
X-gal staining
Parafﬁn-embedded kidney sections were used for immunostaining of
PEDF, picro-sirius red staining, and TUNEL. The anti-PEDF anti-
body (Chemicon, Temecula, CA) was used for immunohistochem-
istry as described previously.26 Picro-sirius staining (Sigma-Aldrich)
and TUNEL were performed according to the manufacturer’s in-
struction (Roche Life Science, Indianapolis, IN). Kidney cryosections
were kept in 24-well plate containing 1 ml of phosphate-buffered
saline with 0.02% NP-40 and 0.1% sodium deoxycholate for 1 to 2
hours at room temperature, and then in 0.5 ml of X-gal staining
solution (Promega, Madison, WI) at 37C overnight.45 Quantiﬁca-
tion of immunohistochemical and picro-sirius red staining images
was obtained by measuring the intensity of staining using the Image
Pro Plus 6.0. Values were the means of 6 to 8 images of each sample.
In situ hybridization
The kidneys were ﬁxed in 4% paraformaldehyde and cryosectioned
at 14 mm. Digoxigenin-labeled PEDF antisense probe and sense
probe (1.2 kb) were synthesized using the Digoxigenin RNA labeling
kit (Roche Life Science) from pBlueScript II SKþ-PEDF plasmid.
Digoxigenin-labeled probes were detected by alkaline phosphatase–
conjugated anti-Digoxigenin antibody (Roche Life Science) and
developed with NBT/BCIP solution (Roche Life Science).63
Statistical analyses
Experiments were performed at least 3 times, and representative data
were presented. All values were expressed as mean  SD. Statistical14comparisons among groups were tested by 1-way analysis of variance
with Tukey’s multiple comparisons. Statistical signiﬁcance was set at
P < 0.05.
DISCLOSURE
All the authors declared no competing interests.ACKNOWLEDGMENTS
We thank Dr. Xiang Wang (Director of the Cell Biology Imaging
Facility) and the Diabetes COBRE Imaging Facility at the University of
Oklahoma Health Science Center and COBRE Diabetic Animal Core for
technical support. This study was supported by NIH grants EY012231,
EY018659, EY019309, EY016507, and GM104934; a fellowship from
the American Heart Association (14PRE20460229); grants from the
Oklahoma Center for the Advancement of Science & Technology
(HR13-076 and HR16-041); and a Rui Cheng’s Juvenile Diabetes
Research Foundation fellowship (3-PDF-2014-107-A-N).SUPPLEMENTARY MATERIAL
Table S1. List of real-time RT-PCR primers.
Table S2. List of antibodies.
Figure S1. Decreased mRNA levels of pigment epithelium-derived
factor (PEDF) in unilateral ureteral obstruction (UUO) kidneys. Real-
time polymerase chain reaction measurement of the PEDF mRNA in
sham kidneys and 5-day UUO kidneys (N ¼ 5). **P < 0.01. Values are
expressed as mean  SD.
Figure S2. Knockout efﬁciency of pigment epithelium-derived factor
(PEDF) in PEDF knockout (PEDF/) mice. (A) Western blot analysis of
PEDF in kidney homogenates from 8-week-old wild-type (WT) mice
kidneys and PEDF/ kidneys under normal conditions (N ¼ 6). (B) In
situ hybridization of the PEDF mRNA in kidney sections of 8-week-old
WT and PEDF/ kidneys under normal conditions. GAPDH glyceral-
dehyde-3-phosphate dehydrogenase.
Figure S3. Normal renal functions in pigment epithelium-derived
factor knock-out (PEDF/) mice. (A) Twenty-four hour urinary
albumin excretion (UAE), (B) urinary albumin/creatinine ratio
(UACR), (C) glomerular ﬁltration rate (GFR) in 8-week-old wild-type
(WT) mice and PEDF/ mice under normal conditions. (D) Periodic
acid–Schiff (PAS) staining of kidney sections of 8-week-old WT and
PEDF/ mice under normal conditions. All values are expressed as
mean  SD.
Figure S4. Higher levels of transforming growth factor-b (TGF-b)
receptors in the kidneys of pigment epithelium-derived factor
knockout (PEDF/) mice with unilateral ureteral obstruction (UUO).
(A,B) Real-time polymerase chain reaction measurement of mRNA
levels, (C) Western blot analysis, and (D,E) densitometry quantiﬁcation
(D and E) of TGF-b receptor type I (TbRI) and type II (TbRII) in the
kidneys from wild-type (WT) mice and PEDF/ mice at day 5 post-
UUO surgery (N ¼ 5–6). *P < 0.05, **P < 0.01, WT/UUO versus WT/
sham; YP < 0.05, PEDF//UUO versus WT/UUO. All values are
expressed as mean  SD. GAPDH, glyceraldehyde-3-phosphate
dehydrogenase.
Figure S5. Increased expression of inﬂammatory factors in the
kidneys of pigment epithelium-derived factor knockout (PEDF/)
mice with unilateral ureteral obstruction (UUO). Real-time polymerase
chain reaction measurement of mRNA levels of interleukin-6 (IL-6)
(A) and macrophage colony–stimulating factor 1 (M-CSF-1) (B) in
the kidneys from wild-type (WT) and PEDF/ mice at day 5 post-
UUO surgery (N ¼ 5–6). **P < 0.01, WT/UUO versus WT/sham;
YP < 0.05, PEDF//UUO versus WT/UUO. All values are expressed
as mean  SD.
Figure S6. Unaffected levels of canonical Wnt ligands in the kidneys
of pigment epithelium-derived factor knockout (PEDF/) mice withKidney International (2016) -, -–-
X He et al.: PEDF and renal tubulointerstitial ﬁbrosis ba s i c re sea r chunilateral ureteral obstruction (UUO). Real-time polymerase chain
reaction measurement of mRNA levels of Wnt1, Wnt2, Wnt2b, Wnt3,
Wnt3a, Wnt8a, Wnt9a, Wnt10b, and Wnt16 in the kidneys from wild-
type (WT) and PEDF/ mice at day 5 post-UUO surgery (N ¼ 5–6). All
values are expressed as mean  SD.
Figure S7. Determination of the purity of primary renal proximal
tubule epithelial cells (PTECs). Representative images of immunostaining
of PTECs using antibodies for the distal convoluted tubule marker
sodium-chloride symporter (NCC) (green) and for the proximal
tubule marker sodium-dependent glucose cotransporter (SGLT-1)
(green), with nuclei counterstained by 40 ,6-diamidino-2-phenylindole
(DAPI) (blue).
Figure S8. Suppression of transforming growth factor-b1 (TGF-b1)–
induced ﬁbrosis by pigment epithelium-derived factor (PEDF). West-
ern blot analysis of ﬁbronectin and connective tissue growth factor
(CTGF) in HKC-8 cells with (A) treatment of 4 ng/ml TGF-b1 and
indicated concentrations of human PEDF for 24 hours and (B) treat-
ment of 4 ng/ml TGF-b1 and adenovirus-mediated expression of
PEDF (Ad-PEDF) for 24 hours. Adenovirus-mediated expression of
green ﬂuorescence protein (Ad-GFP) was used as the control virus.
Supplementary material is linked to the online version of the paper at
www.kidney-international.org.
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